Outbreak of achromobacter xylosoxidans in an italian cystic fibrosis center: Genome variability, biofilm production, antibiotic resistance, and motility in isolated strains

Frontiers in Microbiology

Volumn 5, Issue APR, 2014, Pages

  Trancassini, Maria ^a   Iebba, Valerio ^a   Citerà, Nicoletta ^a   Tuccio, Vanessa ^a   Magni, Annarita ^a   Varesi, Paola ^a   De Biase, Riccardo V ^a   Totino, Valentina ^a   Santangelo, Floriana ^a   Gagliardi, Antonella ^a   Schippa, Serena ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antimicrobial resistance; Biofilm; Cystic fibrosis; Hromobacter xylosoxidans; Motility; RAPD

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; BIOFILM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA EXTRACTION; FORCED EXPIRATORY VOLUME; GENETIC VARIABILITY; HUMAN; INFANT; MIDDLE AGED; MOTILITY ASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; RANDOM AMPLIFIED POLYMORPHIC DNA; SCHOOL CHILD; YOUNG ADULT;

EID: 84899676911     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00138     Document Type: Article

References (39)

1. Amiel, E., Lovewell, R. R., O'toole, G. A., Hogan, D. A., and Berwin, B. (2010). Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect. Immun. 78, 2937-2945. doi: 10.1128/IAI.00144-10
2. Boles, B. R., and Horswill, A. R. (2012). Swimming cells promote a dynamic environment within biofilms. Proc. Natl. Acad. Sci. U.S.A. 109, 12848-12849. doi: 10.1073/pnas.1210297109
3. Bragonzi, A., Farulla, I., Paroni, M., Twomey, K. B., Pirone, L., Lore, N. I., et al. (2012). Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS ONE 7:e52330. doi: 10.1371/journal.pone.0052330
4. Dakin, C. J., Numa, A. H., Wang, H., Morton, J. R., Vertzyas, C. C., and Henry, R. L. (2002). Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165, 904-910. doi: 10.1164/ajrccm.165.7.2010139
5. Ghigo, J. M. (2001). Natural conjugative plasmids induce bacterial biofilm development. Nature 412, 442-445. doi: 10.1038/35086581
6. Hansen, C. R., Pressler, T., Nielsen, K. G., Jensen, P. O., Bjarnsholt, T., and Hoiby, N. (2010). Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 9, 51-58. doi: 10.1016/j.jcf.2009.10.005
7. Hauser, A. R., Jain, M., Bar-Meir, M., and McColley, S. A. (2011). Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 24, 29-70. doi: 10.1128/CMR.00036-10
8. Henrichsen, J. (1983). Twitching motility. Annu. Rev. Microbiol. 37, 81-93. doi: 10.1146/annurev.mi.37.100183.000501
9. Hoffman, L. R., D'argenio, D. A., Maccoss, M. J., Zhang, Z., Jones, R. A., and Miller, S. I. (2005). Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436, 1171-1175. doi: 10.1038/nature03912
10. Hogardt, M., Hoboth, C., Schmoldt, S., Henke, C., Bader, L., and Heesemann, J. (2007). Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 195, 70-80. doi: 10.1086/509821
11. Houry, A., Gohar, M., Deschamps, J., Tischenko, E., Aymerich, S., Gruss, A., et al. (2012). Bacterial swimmers that infiltrate and take over the biofilm matrix. Proc. Natl. Acad. Sci. U.S.A. 109, 13088-13093. doi: 10.1073/pnas.1200791109
12. Jarrell, K. F., and McBride, M. J. (2008). The surprisingly diverse ways that prokaryotes move. Nat. Rev. Microbiol. 6, 466-476. doi: 10.1038/nrmicro1900
13. Lambiase, A., Catania, M. R., Del Pezzo, M., Rossano, F., Terlizzi, V., Sepe, A., et al. (2011). Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 30, 973-980. doi: 10.1007/s10096-011-1182-5
14. Lambiase, A., Raia, V., Del Pezzo, M., Sepe, A., Carnovale, V., and Rossano, F. (2006). Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis. 6:4. doi: 10.1186/1471-2334-6-4
15. Levesque, C., Piche, L., Larose, C., and Roy, P. H. (1995). PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39, 185-191. doi: 10.1128/AAC.39.1.185
16. Liu, L., Coenye, T., Burns, J. L., Whitby, P. W., Stull, T. L., and Lipuma, J. J. (2002). Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 40, 1210-1213. doi: 10.1128/JCM.40.4.1210-1213.2002
17. Macfarlane, S., Bahrami, B., and Macfarlane, G. T. (2011). Mucosal biofilm communities in the human intestinal tract. Adv. Appl. Microbiol. 75, 111-143. doi: 10.1016/B978-0-12-387046-9.00005-0
18. Magni, A., Trancassini, M., Varesi, P., Iebba, V., Curci, A., Pecoraro, C., et al. (2010). Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients. J. Clin. Microbiol. 48, 1035-1039. doi: 10.1128/JCM.02060-09
19. Molin, S., and Tolker-Nielsen, T. (2003). Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr. Opin. Biotechnol. 14, 255-261. doi: 10.1016/S0958-1669(03)00036-3
20. Neuwirth, C., Freby, C., Ogier-Desserrey, A., Perez-Martin, S., Houzel, A., Pechinot, A., et al. (2006). VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France. Emerg. Infect. Dis. 12, 1737-1739. doi: 10.3201/eid1211.060143
21. Pereira, R. H., Carvalho-Assef, A. P., Albano, R. M., Folescu, T. W., Jones, M. C., Leao, R. S., et al. (2011). Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients. J. Clin. Microbiol. 49, 3649-3651. doi: 10.1128/JCM.05283-11
22. Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J. D., et al. (2000). Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44, 891-897. doi: 10.1128/AAC.44.4.891-897.2000
23. Rajan, S., and Saiman, L. (2002). Pulmonary infections in patients with cystic fibrosis. Semin. Respir. Infect. 17, 47-56. doi: 10.1053/srin.2002.31690
24. Rashid, M. H., Rumbaugh, K., Passador, L., Davies, D. G., Hamood, A. N., Iglewski, B. H., et al. (2000). Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 97, 9636-9641. doi: 10.1073/pnas.170283397
25. Raso, T., Bianco, O., Grosso, B., Zucca, M., and Savoia, D. (2008). Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients. APMIS 116, 837-841. doi: 10.1111/j.1600-0463.2008.00995.x
26. Saiman, L., and Siegel, J. (2004). Infection control in cystic fibrosis. Clin. Microbiol. Rev. 17, 57-71. doi: 10.1128/CMR.17.1.57-71.2004
27. Shin, K. S., Han, K., Lee, J., Hong, S. B., Son, B. R., Youn, S. J., et al. (2005). Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron. Diagn. Microbiol. Infect. Dis. 53, 215-220. doi: 10.1016/j.diagmicrobio.2005.06.018
28. Shrout, J. D., Tolker-Nielsen, T., Givskov, M., and Parsek, M. R. (2011). The contribution of cell-cell signaling and motility to bacterial biofilm formation. MRS Bull. 36, 367-373. doi: 10.1557/mrs.2011.67
29. Sibley, C. D., Grinwis, M. E., Field, T. R., Eshaghurshan, C. S., Faria, M. M., Dowd, S. E., et al. (2011). Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS ONE 6:e22702. doi: 10.1371/journal.pone.0022702
30. Sibley, C. D., and Surette, M. G. (2011). The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can. J. Microbiol. 57, 69-77. doi: 10.1139/W10-105
31. Spicuzza, L., Sciuto, C., Vitaliti, G., Di Dio, G., Leonardi, S., and La Rosa, M. (2009). Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur. J. Clin. Microbiol. Infect. Dis. 28, 191-195. doi: 10.1007/s10096-008-0605-4
32. Stepanovic, S., Vukovic, D., Hola, V., Di Bonaventura, G., Djukic, S., Cirkovic, I., et al. (2007). Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115, 891-899. doi: 10.1111/j.1600-0463.2007.apm_630.x
33. Strnad, H., Ridl, J., Paces, J., Kolar, M., Vlcek, C., and Paces, V. (2011). Complete genome sequence of the haloaromatic acid-degrading bacterium Achromobacter xylosoxidans A8. J. Bacteriol. 193, 791-792. doi: 10.1128/JB.01299-10
34. Tan, K., Conway, S. P., Brownlee, K. G., Etherington, C., and Peckham, D. G. (2002). Alcaligenes infection in cystic fibrosis. Pediatr. Pulmonol. 34, 101-104. doi: 10.1002/ppul.10143
35. Traglia, G. M., Almuzara, M., Merkier, A. K., Adams, C., Galanternik, L., Vay, C., et al. (2012). Achromobacter xylosoxidans: an emerging pathogen carrying different elements involved in horizontal genetic transfer. Curr. Microbiol. 65, 673-678. doi: 10.1007/s00284-012-0213-5
36. Tsakris, A., Pournaras, S., Woodford, N., Palepou, M. F., Babini, G. S., Douboyas, J., et al. (2000). Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38, 1290-1292.
37. Vonberg, R. P., and Gastmeier, P. (2005). Isolation of infectious cystic fibrosis patients: results of a systematic review. Infect. Control Hosp. Epidemiol. 26, 401-409. doi: 10.1086/502558
38. Yum, J. H., Yi, K., Lee, H., Yong, D., Lee, K., Kim, J. M., et al. (2002). Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes. J. Antimicrob. Chemother. 49, 837-840. doi: 10.1093/jac/dkf043
39. Zemel, B. S., Jawad, A. F., Fitzsimmons, S., and Stallings, V. A. (2000). Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J. Pediatr. 137, 374-380. doi: 10.1067/mpd.2000.107891